Tuberculosis (TB) is still a prevalent disease, one third of the population is infected by mycobacterium tuberculosis (MT).Treatment with anti TNF therapies appears to increase the risk for developing TB Aim to study the occurrence of latent TB (LTB) or tuberculosis disease (TBD) in children with JIA under anti TNF therapy.
Methods
Clinical records from pts with JIA ( ILAR'01) under anti-TNF therapy were reviewed, focusing on TB screening prior to biologicals , PPD conversion or TBD diagnosiss.LTB was considered as a PPD (TST) positive (≥ 5 mm), in the abscense of radiological manifestations of TB.
Results
105 JIA pts received one or more anti TNF drugs during the observation. Four of them developed LTB and 3 others TBD.
No extrapulmonar TB or miliary forms were observed. All patients were PPD negative prior to biological agents
Conclusions
No significative difference was found between specific anti TNF and the occurrence of LTB or TBD. In 4 pts, the infectious event occurred after 2 ys of exposure and in two earlier as described in the literature. This data highlights the importance of TB surveillance prior to and during anti-TNF therapy. Rheumatology and Tisiology Sections, Hospital de Niños, Dr Ricardo Gutierrez, Buenos Aires, Argentina
